» Human Antithrombin congenital deficient plasma

HEMOSTASIS COAGULATION RESEARCH DEFICIENT PLASMAS CONGENITAL DEFICIENT PLASMAS (BOTTLES)

Human Antithrombin congenital deficient plasma

Packaging in bottle. The minimum packaged volume is 50 mL. The price offer is based on the volume requested.

Reference	6-PPDATC
Presentation	Vial
Format	Minimum 50 mL
Quote

Price list, safety data sheets and notices are accessible to our registered customers.

Reference	Presentation	Format	Quote	Product sheet
6-PPDATC	Vial	Minimum 50 mL

Price list, safety data sheets and notices are accessible to our registered customers.

Previously called antithrombin III (abbreviated ATIII), human antithrombin is one of the major physiological inhibitors of coagulation.
A natural serine protease inhibitor, antithrombin acts mainly on thrombin (IIa) and activated Factor X (FXa), as well as on activated forms of factors IX, XI and XII.
This reaction is catalyzed by heparin.
The normal level of antithrombin is between 80 and 120% in adults and it is about half in newborns.
Antithrombin deficiency predisposes to thrombosis.

Special plasmas are derived from patients with a congenital deficiency, severe or moderate, or presenting a particular profile.
No buffer or preservatives are added.
Quickly frozen at -80° C, the plasma maintains perfectly intact the matrix.
All plasmas are stable when stored at -40° C to -80° C.
We carefully pack with dry ice during shipment.
No additive or preservative.
Expiry date > 1 year.
Plastic vials.

Minimize test time.
Ready to use.

Antithrombin deficient plasma immuno depleted
Antithrombin human deficient plasma (acquired)
Plasma with high antithrombin level

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

HEMOSTASIS COAGULATION RESEARCH DEFICIENT PLASMAS CONGENITAL DEFICIENT PLASMAS (BOTTLES)